 PRINCETON, N.J.--BUSINESS WIRE--UroGen Pharma Ltd. Nasdaq:URGN, a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced that Liz Barrett, President and Chief Executive Officer, will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 4:30 p.m. Eastern Time. The presentation and QA session will be webcast live and can be accessed by visitin 